Permian Resources Free cash flow decreased by 9.9% to $813.12M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.3%, from $896.36M to $813.12M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows an upward trend with a 61.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $106.99M | $153.29M | $192.27M | $159.07M | $293.17M | $387.94M | $527.93M | $437.01M | $420.65M | $479.02M | $842.34M | $644.83M | $937.20M | $951.26M | $865.83M | $896.36M | $1.04B | $760.25M | $901.99M | $813.12M |
| QoQ Change | — | +43.3% | +25.4% | -17.3% | +84.3% | +32.3% | +36.1% | -17.2% | -3.7% | +13.9% | +75.8% | -23.4% | +45.3% | +1.5% | -9.0% | +3.5% | +15.5% | -26.6% | +18.6% | -9.9% |
| YoY Change | — | — | — | — | +174.0% | +153.1% | +174.6% | +174.7% | +43.5% | +23.5% | +59.6% | +47.6% | +122.8% | +98.6% | +2.8% | +39.0% | +10.5% | -20.1% | +4.2% | -9.3% |